Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor

Silvia Salem, Vera Jankowski, Yaw Asare, Elisa Liehn, Pia Welker, Ana Raya-Bermudez, Carmen Pineda-Martos, Mariano Rodriguez, Juan Rafael Munoz-Castaneda, Heike Bruck, Nikolaus Marx, Fernanda B. Machado, Mareike Staudt, Georg Heinze, Walter Zidek, Joachim Jankowski

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)1426-1434
JournalCirculation
Volume131
Issue number16
DOIs
Publication statusPublished - 21 Apr 2015

Keywords

  • angiotensin
  • angiotensin II
  • AT 2 receptor
  • peptides
  • vasoconstriction

Cite this

Salem, S., Jankowski, V., Asare, Y., Liehn, E., Welker, P., Raya-Bermudez, A., Pineda-Martos, C., Rodriguez, M., Rafael Munoz-Castaneda, J., Bruck, H., Marx, N., Machado, F. B., Staudt, M., Heinze, G., Zidek, W., & Jankowski, J. (2015). Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor. Circulation, 131(16), 1426-1434. https://doi.org/10.1161/CIRCULATIONAHA.114.013168